Commonwealth Equity Services’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $209K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $980K | Buy |
|
|||||
|
2021
Q3 | $214K | Hold |
|
|||||
|
2021
Q2 | $202K | Sell |
|
|||||
|
2021
Q1 | $239K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $233K | Buy |
|
|||||
|
2020
Q2 | $264K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $217K | Sell |
|
|||||
|
2019
Q3 | $259K | Sell |
|
|||||
|
2019
Q2 | $572K | Buy |
|
|||||
|
2019
Q1 | $483K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $438K | Buy |
|
|||||
|
2018
Q2 | $217K | Sell |
|
|||||
|
2018
Q1 | $199K | Sell |
|
|||||
|
2017
Q4 | $205K | Sell |
|
|||||
|
2017
Q3 | $226K | Hold |
|
|||||
|
2017
Q2 | $201K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $476K | Buy |
|
|||||
|
2016
Q3 | $380K | Sell |
|
|||||
|
2016
Q2 | $509K | Sell |
|
|||||
|
2016
Q1 | $644K | Sell |
|
|||||
|
2015
Q4 | $659K | Buy |
|
|||||
|
2015
Q3 | $347K | Buy |
|
|||||
|
2015
Q2 | $205K | Sell |
|
|||||
|
2015
Q1 | $267K | Sell |
|
|||||
|
2014
Q4 | $340K | Sell |
|
|||||
|
2014
Q3 | $309K | Buy |
|